• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Dyax Corp. (DYAX)

    -NasdaqGM
    16.16 Up 0.17(1.06%) Jan 27, 4:00PM EST
    |After Hours : 16.16 0.00 (0.00%) Jan 27, 4:50PM EST
    Add to Portfolio
    Prev Close:15.99
    Open:15.71
    Bid:12.10 x 400
    Ask:N/A
    1y Target Est:15.06
    Beta:0.64
    Earnings Date:Feb 26 - Mar 2 (Est.)
    Day's Range:15.71 - 16.39
    52wk Range:6.05 - 16.39
    Volume:760,578
    Avg Vol (3m):1,069,300
    Market Cap:2.20B
    P/E (ttm):N/A
    EPS (ttm):-0.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DYAXUp 1.06%2.20B
    SHPGUp 0.19%43.29B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):30.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.11
    Quarterly EPS Est (Dec-14) :-0.04
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-7.58

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback